Evaluation of Effect on Sensory and Motor Block Parameters with Supplementation of Low Dose Intravenous Dexmedetomidine on Characteristics of Spinal Anaesthesia with Hyperbaric Bupivacaine

Main Article Content

Pulin Bansal
Mahima Lakhanpal
Shefali Singh
Abhishek Singh
Rahul Singh

Abstract

Background: The most typical symptom that prompts patients to visit a doctor is pain. Pain is an experience as well as a sensory modality. People's reactions to pain might vary greatly from one another as well as from moment to moment within the same person.


Aim and Objective: The purpose of the current study was to determine the impact of adding low dosage intravenous dexmedetomidine to spinal anaesthesia to study how sensory and motor block parameters changed.


Methodology: The current study was conducted at Santosh Medical College & Hospital in Ghaziabad on 50 patients who were ASA l & ll and had lower abdomen and lower limb procedures. The patients' ages ranged from 18 to 65, and their weights ranged from 30 to 70 kg for both sexes.


Result: In the study's sample, there were 32 men and 18 women. The mean age in groups D was 36.28 + 12.70 years, compared to 39.36 + 13.43 years in groups C. Mean onset  time  of  sensory  block  was  reported  as 5.95±3.486 in group D and 7.90±3.538 in group C which was statistically significant, p=0.001 Mean VAS score in the D & C group remained zero for 90 minutes after the administration of the drug.


Conclusion: Dexmedetomidine group's sensory block onset time is earlier. The study found that Dexmedetomedine administered intravenously during spinal anesthesia decreased the onset and maximum motor blockage of sensory blocks.

Article Details

How to Cite
Bansal, P. ., Lakhanpal, M. ., Singh, S. ., Singh, A. ., & Singh, R. . (2022). Evaluation of Effect on Sensory and Motor Block Parameters with Supplementation of Low Dose Intravenous Dexmedetomidine on Characteristics of Spinal Anaesthesia with Hyperbaric Bupivacaine. Journal of Coastal Life Medicine, 10(3), 779–784. Retrieved from https://www.jclmm.com/index.php/journal/article/view/261
Section
Articles

References

Mighty things from small beginning grow’ John Dryen (1631-1700) Annus mirabilis. Anaesthesia. 1999;54(9):823-825.

Stappendal R., Weber E.W., Benraad B., Van Limbeek J., Dirksen R., itching after intrathecal morphine, incidence and treatment, eur j anaesthesiol 2000;17:616-21.

Kanazi GE, Aouad MT, Jabbour-Khoury SI, Al Jazzar MD,Alameddine MM, Al-Yaman R, Bulbul M, Baraka AS. Effect of low-dose dexmedetomidine or clonidine on the characteristics of bupivacaine spinal block. Acta Anaesthesiol Scand 2006;50:222–7

Al-Mustafa MM, Abu-Halaweh SA, Aloweidi AS, Murshidi MM, Ammari BA, Awwad ZM, Al-Edwan GM, Ramsay MA. Effect of dexmedetomidine added to spinal bupivacaine for urological procedures. Saudi Med J 2009;30:365–70

Eid H, Shafie M, Youssef H. Dose-related prolongation of hyperbaric bupivacaine spinal anesthesia by dexmedetomidine. Ain Shams J Anesthesiology 2011;4:83–95

Parkhouse J, Lambrechts W, Simpson BRL- The incidence of postoperative pain. Br J Anaesth 1961;33:345-353

Gupta R, Bogra J, Verma R, Kohli M, Kushwaha JK, Kumar S. Dexmedetomidine as an intrathecal adjuvant for postoperative analgesia. Indian J Anaesth 2011;55:347–51

Shukla D, Verma A, Agarwal A, Pandey HD, Tyagi C. Comparative study of intrathecal dexmedetomidine with intrathecal magnesium sulfate used as adjuvants to bupivacaine. J Anaesthesiol Clin Pharmacol 2011;27:495–9

Bonica JJ, Yaksh T, Liebeskind JC, Pechick RN, De Paulis A; Biochemistry and modulation of nociception and pain. Philadelphia; Lea and Febiger 1990;95-121.

Corning J.L.N.Y. Med. J. 1885;42:483(reprinted in ‘Classical File’, Survey of Anaesthesiology 1960;4:332)

Lund PC. Principles and Practice of Spinal Anesthesia. Springfield, IL: Charles C. Thomas, 1971.

Deutsh. Zeit. F. Chir. 1899;51:361(translated and reprinted in ‘Classical File’, Bier Survey of Anesthesiology 1962;6:352).

SS Harsoor, D Devika Rani, Bhavana Yalamuru, K Sudheesh, SS Nethra. Effect of supplementation of low dose intravenous dexmedetomidine on characteristics of spinal anaesthesia with hyperbaric bupivacaine. Indian J Anaesth 2013;57:265-269

Anbarasu Annamalai, Sanjeev Singh, Arti Singh and Deigheidy Ehab Mahrous. Can Intravenous Dexmedetomidine Prolong Bupivacaine Intrathecal Spinal Anesthesia? J Anesth Clin Res 2013;4:372.

Al-Ghanem SM, Massad IM, Al-Mustafa MM, Al- Zaben KR, Qudaisat IY, Qatawneh AM, et al. Effect of adding dexmedetomidine versus fentanyl to intrathecal bupivacaine on spinal block characteristics in gynaecological procedures: A double blind controlled study. Americal Journal of Applied Sciences 2009;6:882-887.

Lugo VW, Gomez IA, Cisneros, Corral R, Martinez, Gallegos N. Intravenous dexmedetomidine versus intravenous clonidine to prolong bupivacaine spinal anaesthesia. A double blind study. Anestesia en Mexico 2007;19:143‑6

Revill SI, Robinson JO: The reliability of linear analogue for evaluating pain. Analogue for evaluating pain. Anesth 1976;31:1191-1198.

Moorf M, Khan SA, Jain D, Khan RM, Maroof SM. Evaluation of effect of dexmedetomidine in reducing shivering following epidural anesthesia. Anesthesiology 2004;101:495.

Kaya FN, Yavascaoglu B, Turker G, Yildirim A, Gurbet A, Mogol EB, et al. Intravenous dexmedetomidine, but not midazolam, prolongs bupivacaine spinal anesthesia. Can J Anaesth 2010;57:39-45